Effect Of Micronised Progesterone On Endometrial Receptivity

Investigation Of Endometrial Receptivity Parameters At Mid Secretory Phase When Micronised Progesterone Added During Luteal Phase in infertile Patients with Polycistic Ovaries and Unexplained Infertility

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12610000195055

Enrollment

Registered

2010-03-08

Start date

2010-03-15

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

primary purpose is to investigate the effect of micronised progesterone as luteal phase support on endometrium receptivity in polycystic ovaries and unexplained infertility patients.Gylcodelin,leukemia inhibitory factor and interleukin 11 are well previously defined cytokines that related with embryo implantation especially at mid secretory phase of the cycle

Interventions

patients will take oral clomiphene citrate of 2 tablets(100 mg) each day,beginning at fifth day of menstruel cycle for five days.stusy group will then take micronised progesterone , 2 capsule of 200 mg(400 mg/day)beginning just after ovulation for 14 days

Study design

Allocation

Randomised controlled trial

Primary purpose

Treatment

Eligibility

Sex/Gender

All

Age

20 Years to 39 Years

Healthy volunteers

Yes

Inclusion criteria

INFERTILE PATIENTS OF POLYCYSTIC OVARIES AND UNEXPLAINED INFERTILITY 20-39 YEARS OLD NO SYSTEMIC DISEASES

Exclusion criteria

INFERTILITY OTHER THAN polycystic ovaries(PCO) AND UNEXPLAINED,SYSTEMIC DISEASES,DRUG USERS,OVARIAN OR ENDOMETRIAL PATHOLOGIES SUCH AS MYOMA,ENDOMETRIOSIS

Outcome results